Cargando…
Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India
Current Indian guidelines recommend twice-annual CD4 testing to monitor first-line antiretroviral therapy (ART), with a plasma HIV RNA test to confirm failure if CD4 declines, which would prompt a switch to second-line ART. We used a mathematical model to assess the clinical benefits and cost-effect...
Autores principales: | Freedberg, Kenneth A., Kumarasamy, Nagalingeswaran, Borre, Ethan D., Ross, Eric L., Mayer, Kenneth H., Losina, Elena, Swaminathan, Soumya, Flanigan, Timothy P., Walensky, Rochelle P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994680/ https://www.ncbi.nlm.nih.gov/pubmed/29620932 http://dx.doi.org/10.1089/aid.2017.0258 |
Ejemplares similares
-
Clinical Impact and Cost-Effectiveness of Expanded Voluntary HIV Testing in India
por: Venkatesh, Kartik K., et al.
Publicado: (2013) -
The Cost-Effectiveness of Tuberculosis Preventive Therapy for HIV-Infected Individuals in Southern India: A Trial-Based Analysis
por: Pho, Mai T., et al.
Publicado: (2012) -
Cost-Effectiveness of HIV Testing Referral Strategies among Tuberculosis Patients in India
por: Uhler, Lauren M., et al.
Publicado: (2010) -
The Survival Benefits of Antiretroviral Therapy in South
Africa
por: April, Michael D., et al.
Publicado: (2014) -
The cost‐effectiveness and budgetary impact of a dolutegravir‐based regimen as first‐line treatment of HIV infection in India
por: Zheng, Amy, et al.
Publicado: (2018)